Sintx Technologies (NASDAQ:SINT – Get Free Report) and Avinger (NASDAQ:AVGR – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, analyst recommendations, valuation and risk.
Analyst Ratings
This is a breakdown of current recommendations and price targets for Sintx Technologies and Avinger, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Sintx Technologies | 0 | 1 | 0 | 0 | 2.00 |
| Avinger | 0 | 0 | 1 | 0 | 3.00 |
Avinger has a consensus target price of $5.00, indicating a potential upside of 719.67%. Given Avinger’s stronger consensus rating and higher possible upside, analysts clearly believe Avinger is more favorable than Sintx Technologies.
Earnings & Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Sintx Technologies | $1.64 million | 2.92 | -$8.26 million | ($50.56) | -0.07 |
| Avinger | $7.26 million | 0.28 | -$18.32 million | ($11.06) | -0.06 |
Sintx Technologies has higher earnings, but lower revenue than Avinger. Sintx Technologies is trading at a lower price-to-earnings ratio than Avinger, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
18.4% of Sintx Technologies shares are held by institutional investors. Comparatively, 18.3% of Avinger shares are held by institutional investors. 0.0% of Sintx Technologies shares are held by company insiders. Comparatively, 42.8% of Avinger shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Profitability
This table compares Sintx Technologies and Avinger’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Sintx Technologies | -358.79% | -140.68% | -78.29% |
| Avinger | -261.06% | -5,527.11% | -123.25% |
Volatility & Risk
Sintx Technologies has a beta of 1.49, indicating that its stock price is 49% more volatile than the S&P 500. Comparatively, Avinger has a beta of 1.15, indicating that its stock price is 15% more volatile than the S&P 500.
Summary
Avinger beats Sintx Technologies on 8 of the 14 factors compared between the two stocks.
About Sintx Technologies
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
About Avinger
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.
Receive News & Ratings for Sintx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sintx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
